APA 6th Edition

Debeljak, T. & KoresPlesničar, B. (2021). DISTINGUISHING BETWEEN NEUROLEPTIC MALIGNANT SYNDROME AND SEROTONIN SYNDROME IN POLYPHARMACY: AN OVERVIEW WITH A CASE REPORT. Psychiatria Danubina, 33 (suppl 2), 162-162. Retrieved from https://hrcak.srce.hr/270017

---

MLA 8th Edition

Debeljak, Tana and Blanka KoresPlesničar. "DISTINGUISHING BETWEEN NEUROLEPTIC MALIGNANT SYNDROME AND SEROTONIN SYNDROME IN POLYPHARMACY: AN OVERVIEW WITH A CASE REPORT." Psychiatria Danubina, vol. 33, no. suppl 2, 2021, pp. 162-162. https://hrcak.srce.hr/270017. Accessed 20 May 2024.

---

Chicago 17th Edition

Debeljak, Tana and Blanka KoresPlesničar. "DISTINGUISHING BETWEEN NEUROLEPTIC MALIGNANT SYNDROME AND SEROTONIN SYNDROME IN POLYPHARMACY: AN OVERVIEW WITH A CASE REPORT." Psychiatria Danubina 33, no. suppl 2 (2021): 162-162. https://hrcak.srce.hr/270017

---

Harvard

Debeljak, T., and KoresPlesničar, B. (2021). 'DISTINGUISHING BETWEEN NEUROLEPTIC MALIGNANT SYNDROME AND SEROTONIN SYNDROME IN POLYPHARMACY: AN OVERVIEW WITH A CASE REPORT', Psychiatria Danubina, 33(suppl 2), pp. 162-162. Available at: https://hrcak.srce.hr/270017 (Accessed 20 May 2024)

---

Vancouver

Debeljak T, KoresPlesničar B. DISTINGUISHING BETWEEN NEUROLEPTIC MALIGNANT SYNDROME AND SEROTONIN SYNDROME IN POLYPHARMACY: AN OVERVIEW WITH A CASE REPORT. Psychiatria Danubina [Internet]. 2021 [cited 2024 May 20];33(suppl 2):162-162. Available from: https://hrcak.srce.hr/270017

---

IEEE

T. Debeljak and B. KoresPlesničar, "DISTINGUISHING BETWEEN NEUROLEPTIC MALIGNANT SYNDROME AND SEROTONIN SYNDROME IN POLYPHARMACY: AN OVERVIEW WITH A CASE REPORT", Psychiatria Danubina, vol.33, no. suppl 2, pp. 162-162, 2021. [Online]. Available: https://hrcak.srce.hr/270017. [Accessed: 20 May 2024]